News for 'VPRO' - (Viropro Provides Company Updates)
IRVINE, Calif., Jul 29, 2011 (BUSINESS WIRE) -- VIROPRO (Pink Sheets: VPRO)
today provided updates on its business.
Stockholders meeting was postponed because items to be voted upon by
stockholders required production of the audited financial statements and these
are not yet available. Company considered other alternative but all required
filing of these statements.
Delays in production of financials are attributable to change of accounting
firm, from a Canadian CPA firm, to a US CPA firm and the need to consolidate the
Company's new subsidiaries. Work on the financials is now progressing smoothly
and production of 2010 Q2 and Q3 should be completed shortly. Company intends on
returning to full disclosure as early as possible.
Management also received numerous questions relating to the Spectrum agreement
announced back in January. As per this agreement, the Company cannot comment on
the progress of the work being done and cannot either disclose the amount of the
agreement but can simply state that Spectrum is so far very satisfied with the
work done. Company will give more details when Spectrum grants permission to do
so.
About Viropro, Inc.:
Viropro, Inc. conducts operations through its subsidiaries Viropro International
Inc., and Biologics Process Development, Inc. and specializes in the transfer of
its technologies for industrial production of biopharmaceutical therapeutic
proteins for the treatment of various diseases including cancer, diabetes,
hepatitis and multiple sclerosis. The Company's principal objective is to
provide its high-yield manufacturing process technology to biopharmaceutical
companies in global markets with unmet medical and/or market needs.
(www.viropro.com)
Viropro, Inc. Safe Harbor Statement
Except for any historic information contained herein, the matters discussed in
this press release contain forward-looking statements that involve risks and
uncertainties, which are subject to section 27A of the Securities Act of 1933
and section 21E of the Exchange Act of 1934, and are subject to safe harbor
created by these sections. Any statements that express or involve discussions
with respect to predictions, beliefs, plans, projections, objectives, goals,
assumptions of future events or performances are not statements of historical
fact and may be "forward-looking statements". Forward-looking statements in this
release may be identified through the use of such words as "expects",
"anticipates", "estimates", "believes", or statements indicating certain actions
"may", "could", or "might" occur. Actual results, performance or achievements
could differ materially from those anticipated in such forward-looking
statements, which involve numerous risks and uncertainties, including the
Company's ability to market its products and services in a competitive
environment as well as other factors.
SOURCE: Viropro, Inc.
CONTACT:
Viropro, Inc.
Serge Beausoleil, 514-779-7336
AI
